0.000USD0.000Pre-market 08/03, 09:30 (ET)
544.98MMarket Cap
LossP/E TTM
Key Figures
4.280Open
4.310High
608.89KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.47%Turnover Ratio
4.310Prev. Close
4.135Low
1.68MTurnover
LossP/E Static
1.59P/B
0.00%Div Yield TTM
-15.89%ROA
6.18052wk High
1.03Volume Ratio
-6.02MNet Profit
128.55MShares
-0.5786EPS TTM
1.19Beta
-20.93%ROE
2.46052wk Low
4.06%Amplitude
48.16%Gross Margin
544.98MMarket Cap
-2.00Reward/Risk
3.36%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Cytek Biosciences Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 85 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.69.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cytek Biosciences Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Cytek Biosciences Inc Highlights
StrengthsRisks
Cytek Biosciences Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Cytek Biosciences Inc
CTKB
4
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Cytek Biosciences Inc Info
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Ticker SymbolCTKB
CompanyCytek Biosciences Inc
CEOJiang (Wenbin)
Websitehttps://cytekbio.com
Shareholders
FAQs
What is the current price of Cytek Biosciences Inc (CTKB)?
The current price of Cytek Biosciences Inc (CTKB) is 4.22.
What is the symbol of Cytek Biosciences Inc?
The ticker symbol of Cytek Biosciences Inc is CTKB.
What is the 52-week high of Cytek Biosciences Inc?
The 52-week high of Cytek Biosciences Inc is 6.18.
What is the 52-week low of Cytek Biosciences Inc?
The 52-week low of Cytek Biosciences Inc is 2.46.
What is the market capitalization of Cytek Biosciences Inc?
The market capitalization of Cytek Biosciences Inc is 544.98M.
Is Cytek Biosciences Inc (CTKB) currently rated as Buy, Hold, or Sell?
According to analysts, Cytek Biosciences Inc (CTKB) has an overall rating of Buy, with a price target of 5.69.
What is the Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB)?
The Earnings Per Share (EPS TTM) of Cytek Biosciences Inc (CTKB) is -0.52.